Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Cancer%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Cancer%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Cancer%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (100.878)
1
A study to compare treatment after surgery of abemaciclib combined with standard endocrine therapy versus endocrine therapy alone in patients with early stage breast cancer : A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High-Risk, Node-Positive, Early-Stage, Hormone Receptor-Positive, Human Epidermal Receptor 2-Negative, Breast Cancer - MonarchE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A clinical trial for advanced prostatic cancer patients . The study medication will be Leuprolide Mesylate, which will be administered as an injection twice. Both the study doctors and clinical trial participants know which treatment is being administered, there will be only one treatment group.The safety and efficacy of the medicinal product will be tested during the study. : An Open-Label, Single-Arm Study of the Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate for Injectable Suspension (LMIS 50 mg) in Subjects with Advanced Prostate Carcinoma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Study with investigational drug PF-06463922 and comparator crizotinib in patients with a specific type of advanced lung cancer : A Phase 3, randomized, open label study of lorlatinib (PF 06463922) monotherapy versus crizotinib monotherapy in the first line treatment of patients with advanced ALK positive non small cell lung cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC) : An Exploratory Study of the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A study to compare the efficacy and safety of bb2121 to standard treatment in people who have Myeloma that is not responsive after treatment or who had Myeloma which has returned after a period of treatment. : A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of BB2121 Versus Standard Triplet Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (Rrmm) (KarMMa-3)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Study to Evaluate the Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab and CHP (R-CHP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma : A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL COMPARING THE EFFICACY AND SAFETY OF POLATUZUMAB VEDOTIN IN COMBINATION WITH RITUXIMAB AND CHP (R-CHP) VERSUS RITUXIMAB AND CHOP (R-CHOP) IN PREVIOUSLY UNTREATED PATIENTS WITHDIFFUSE LARGE B-CELL LYMPHOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Evaluating the efficacy and safety of pertuzumab in combination with trastuzumab and chemotherapy in patients with HER2-positive metastatic gastro-esophageal junction and gastric cancer : A double-blind, placebo-controlled, randomized, multicenter phase III study evaluating the efficacy and safety of pertuzumab in combination with trastuzumab and chemotherapy in patients with HER2-positive metastatic gastro-esophageal junction and gastric cancer - JACOB
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A trial of oral azacitidine compared to standard treatment in patients with relapsed lymphoma. : Randomized Phase 3 Study evaluating the Efficacy and the Safety of Oral Azacitidine (CC-486) compared to Investigator’s Choice Therapy in Patient with Relapsed or Refractory Angioimmunoblastic T cell Lymphoma - ORACLE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Evaluation of pomalidomide with dexamethasone (low dose) in patients with Multiple Myeloma (MM)whose disease did not respond to the previous treatment or, has come back after the previous treatment. : A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY WITH POMALIDOMIDE IN COMBINATION WITH LOW DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A phase 3 trial studying how well E7080 works in treating patients with advanced thyroid cancer who no longer gain benefit from radioactive iodine therapy. The trial is taking place worldwide, patients and their physician do not know if they are receiving the active drug or a dummy drug. : A Multicenter, Randomized, Double-Blind, Placebo-Controlled,Phase 3 Trial of Lenvatinib E7080 in 131I-Refractory Differentiated Thyroid Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[10088]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
100.878
Aufsätze
100.878
E-Artikel
100.878
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
100.878
610
86.650
Study Type: Interventional
38.798
Recruitment Status: Not yet recruiting
21.446
Recruitment Status: Authorised-recruitment may ...
20.880
Phase: Phase 3
20.424
Phase: Phase 2
17.272
Recruitment Status: Recruiting
10.714
Study Type: Observational
10.356
Recruitment Status: Completed
8.036
Recruitment Status: Complete: follow-up complete
6.198
Phase: Phase 1
2.048
Recruitment Status: Complete: follow-up continuing
1.696
Phase: Phase 4
1.402
Phase: Phase 1/Phase 2
1.392
Study Type: Diagnostic test
1.224
Phase: Other
1.126
Medical Condition: Breast cancer
1.080
Medical Condition: breast cancer
982
Medical Condition: lung cancer
912
Medical Condition: colorectal cancer
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
64.076
2020-
36.802
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
98.484
Englisch
1.308
Unbestimmt
492
Spanisch
212
Niederländisch
204
Französisch
52
Deutsch
34
Dänisch
26
Italienisch
16
Finnisch
10
Schwedisch
6
Tschechisch
4
Afrikaans
4
Corsican
4
Frisian
4
Portugiesisch
2
Ungarisch
2
Isländisch
2
Indonesisch
2
Norwegisch
2
Slowakisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...